CV Sciences Inc.
The American-based operation at CV Sciences is split across two fronts. The first, consumer products, supplies hemp-derived CBD oils through a subsidiary branded “PlusCBD Oil”. The second focus for the company is the pursuit of pharmaceutical-grade drugs with cannabidiol as the active ingredient. With the support of preclinical results, they are actively pursuing FDA approval for medication aimed at a range of health conditions.
The American-based operation at CV Sciences is split across two fronts. The first, consumer products, supplies hemp-derived CBD oils through a subsidiary branded “PlusCBD Oil”. The second focus for the company is the pursuit of pharmaceutical-grade drugs with cannabidiol as the active ingredient. With the support of preclinical results, they are actively pursuing FDA approval for medication aimed at a range of health conditions.
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
CVSI |
$197,789
|
100% |
$0.5700
|
